OpenAI acquires startup Orchestra Bio to beef up its biotech business
Covered by 5 sources
Read the full article
OpenAI acquired Orchestra Bio, a biotech AI software startup, to enhance its Rosalind life sciences AI model and Workbench tool, which aid drug discovery and research planning. Orchestra's technology and team will integrate to support pharma clients like Moderna and Novo Nordisk.
